login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
Novus Therapeutics Inc (NVUS) Stock News
NASDAQ:NVUS -
14.6
-0.8 (-5.19%)
Last: 1/4/2021, 8:00:01 PM
15.75
+1.15 (+7.88%)
After Hours:
1/4/2021, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NVUS Latest News, Press Relases and Analysis
All
Press Releases
5 years ago - By: Benzinga
- Mentions:
BEAT
AEMD
ONVO
MREO
...
12 Health Care Stocks Moving In Friday's Intraday Session
5 years ago - By: Novus Therapeutics, Inc.
Novus Therapeutics Appoints June Lee, M.D., to Board of Directors
5 years ago - By: Benzinga
- Mentions:
ACOR
MNKD
OMER
MACK
...
12 Healthcare Stocks Moving In Wednesday's After-Market Session
5 years ago - By: BusinessInsider
Novus Therapeutics Reports Third Quarter 2020 Financial Results
5 years ago - By: Novus Therapeutics, Inc.
Novus Therapeutics Reports Third Quarter 2020 Financial Results
5 years ago - By: BusinessInsider
Novus Therapeutics to Release Third Quarter 2020 Financial Results on Monday, November 16
5 years ago - By: Novus Therapeutics, Inc.
Novus Therapeutics to Release Third Quarter 2020 Financial Results on Monday, November 16
5 years ago - By: Novus Therapeutics, Inc.
Novus Therapeutics Announces First Patient Enrolled in Phase 2a Clinical Trial of Anti-CD40L Antibody AT-1501 in Amyotrophic Lateral Sclerosis
5 years ago - By: Seeking Alpha
- Mentions:
KNSA
HGEN
STIM
AMWL
...
Kiniksa Pharmaceuticals, Humanigen leads healthcare gainers, Corbus Pharmaceuticals, Axovant Gene Therapies among major losers
5 years ago - By: Zacks Investment Research
Moving Average Crossover Alert: Novus Therapeutics
5 years ago - By: Novus Therapeutics, Inc.
Novus Therapeutics Announces One-for-Eighteen Reverse Stock Split
5 years ago - By: PennyStocks.com
- Mentions:
NAK
PRPO
IZEA
EVGN
5 Top Penny Stocks On Robinhood To Watch As Markets Sell-Off
5 years ago - By: Zacks Investment Research
- Mentions:
AZN
PFE
GILD
IMMU
...
Healthcare ETFs, Stocks That Gained Double Digits Last Week
5 years ago - By: Seeking Alpha
- Mentions:
PLAY
XBIO
INO
NNOX
...
MRSN, FSLR among premarket losers
5 years ago - By: Seeking Alpha
- Mentions:
ARWR
KODK
INO
RENN
...
INO, ARWR, ADT and AXL among midday movers
5 years ago - By: Seeking Alpha
- Mentions:
ARWR
AXGN
CVET
INO
...
Arrowhead Pharmaceuticals, Myomo leads healthcare gainers, Novus Therapeutics, Jounce Therapeutics among major losers
5 years ago - By: Seeking Alpha
- Mentions:
ADT
NNOX
PSTV
NKLA
...
ADT, NKLA among premarket losers
5 years ago - By: Novus Therapeutics, Inc.
Novus Therapeutics to Present at H.C. Wainwright and Cantor Global Investment Conferences
Please enable JavaScript to continue using this application.